HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment-resistant Churg-Strauss syndrome: progression after five years using rituximab.

AuthorsMaría Martínez-Villaescusa, Aurora López-Montes, Esperanza López-Rubio, Lourdes de la Vara-Iniesta, Marina Méndez-Molina, Dionisio Donate-Ortiz, Hyun Nam-Cha, Carmen Gómez-Roldán
JournalNefrologia : publicacion oficial de la Sociedad Espanola Nefrologia (Nefrologia) Vol. 33 Issue 5 Pg. 737-9 ( 2013) ISSN: 1989-2284 [Electronic] Spain
PMID24089169 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal, Murine-Derived
  • Immunosuppressive Agents
  • Rituximab
  • Cyclophosphamide
  • Prednisone
  • Methylprednisolone
Topics
  • Aged
  • Antibodies, Monoclonal, Murine-Derived (therapeutic use)
  • Biopsy
  • Churg-Strauss Syndrome (drug therapy, immunology, therapy)
  • Combined Modality Therapy
  • Cyclophosphamide (adverse effects, pharmacology, therapeutic use)
  • Disease Progression
  • Drug Resistance
  • Glomerulonephritis (etiology, pathology, therapy)
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Kidney (pathology)
  • Male
  • Methylprednisolone (pharmacology, therapeutic use)
  • Plasmapheresis
  • Prednisone (pharmacology, therapeutic use)
  • Remission Induction
  • Renal Dialysis
  • Rituximab

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: